Responses
Regular and Young Investigator Award Abstracts
Clinical Trials Completed
334 Phase I study of safety and activity of personalized neoantigen-based vaccines in combination with tumor treating fields for newly diagnosed glioblastoma patients
Compose a Response to This Article
Other responses
No responses have been published for this article.